All You Need to Know About Caribou Biosciences, Inc. (CRBU) Rating Upgrade to Buy

Investors might want to bet on Caribou Biosciences, Inc. (CRBU) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the sy ...